Embracing AI for Future Leadership: Paul Hudson’s Talk with Lindsay Levin at TED

In a thought-provoking conversation with TED’s Lindsay Levin recently, pharmaceutical CEO Paul Hudson shared his vision for embracing AI within the pharmaceutical industry, focusing attention on its transformative potential.

Hudson, at the helm of Sanofi, expressed an ambitious goal: “We aim to be the world’s leading pharmaceutical company using AI at scale,” he said. This vision is not just aspirational but actively pursued, with Hudson revealing: “We have 23,000 people using AI as often as every month, 9,000 people in the company using AI as often as every day.”

Hudson’s insights into AI’s role in pharmaceuticals were not just about adopting new technologies but also about the cultural shifts necessary to innovate effectively.

He addressed the common apprehensions surrounding AI.

“For some people it’s Skynet and Terminator,” he said. “For some people, they confuse AI with cyber.” Yet, he stands firm on the potential of AI. “If it is the fourth industrial revolution, which we believe it is,” continued Hudson, “then hesitating, this fear that can take over, can deprive you of so much opportunity.”

The conversation also touched on the broader implications of AI beyond just technological advancements. Hudson pointed out the shift towards more meaningful work that AI could facilitate.

“The adoption of AI in particular is not about jobs,” he said. “More meaningful work is created.”

He highlighted the direct impact of AI on enhancing decision-making processes and operational efficiencies, ultimately leading to a competitive advantage.

Hudson also provided a candid look into the challenges of leading a major pharmaceutical company through such transformative times. He shared his experience with radical data transparency brought about by AI, where “You can see their data real-time.”

This level of openness has been both a challenge and an opportunity, pushing the organization towards greater accuracy and accountability.

Hudson’s conversation with Levin at TED not only shed light on the strategic incorporation of AI in Sanofi’s operations but also offered a glimpse into the future of leadership in the face of disruptive technologies. His call for leaders to embrace AI, to disrupt the status quo, and to foster a culture of innovation and agility resonates across industries, marking a pivotal moment in the journey towards the next industrial revolution.

Featured image: Credit TED

Need Deeper Intelligence on the AI Market?

AI Insider's Market Intelligence platform tracks funding rounds, competitive landscapes, and technology trends across the global AI ecosystem in real time. Get the data and insights your organization needs to make informed decisions.

Related Articles

selective focus photography of anatomy lungs
Guest Post: The Biggest Opportunity to Improve Lung Cancer Survival Isn’t a New Drug

Guest Post by: Chris Wood, CEO of RevealDX Improvements in early cancer detection have historically contributed more to mortality reduction than drugs designed to treat

Hyundai Moving to Buy SoftBank’s Remaining Stake in Boston Dynamics

Insider Brief Hyundai Motor Group shareholders are pursuing the acquisition of SoftBank’s entire stake in Boston Dynamics under existing agreements between the parties. According to

25 London-Based AI Scale-Ups You Need to Know in 2026

London has quietly become one of the deepest benches of applied AI talent outside Silicon Valley. The city’s scale-ups are not chasing headlines about general

Stay Updated with AI Insider

Get the latest AI funding news, market intelligence, and industry insights delivered to your inbox weekly.

$ 0 M

Seed round tracked

Gitar — Code Validation

Get the Weekly Briefing

Funding analysis, market intelligence, and industry trends delivered to your inbox every week.

Need bespoke intelligence?

Our team combines real-time data with decades of sector experience to guide your decisions.

Subscribe today for the latest news about the AI landscape